Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium in epilepsy
IRCT20101209005352N3Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of selenium in epilepsy, sponsored by Zanjan University of Medical Sciences. Started Aug 2018; status: completed.
02
Drugs
selenium
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20101209005352N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101209005352N3.